Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.
Publication
, Journal Article
Cammarata, M; Denvir, B; Singh, A; Wang, B; Antiochos, B; Geetha, D
Published in: Kidney Int Rep
June 2025
Duke Scholars
Published In
Kidney Int Rep
DOI
EISSN
2468-0249
Publication Date
June 2025
Volume
10
Issue
6
Start / End Page
2065 / 2068
Location
United States
Related Subject Headings
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Cammarata, M., Denvir, B., Singh, A., Wang, B., Antiochos, B., & Geetha, D. (2025). Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis. Kidney Int Rep, 10(6), 2065–2068. https://doi.org/10.1016/j.ekir.2025.04.026
Cammarata, Michael, Brendan Denvir, Aditi Singh, Bangchen Wang, Brendan Antiochos, and Duvuru Geetha. “Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.” Kidney Int Rep 10, no. 6 (June 2025): 2065–68. https://doi.org/10.1016/j.ekir.2025.04.026.
Cammarata M, Denvir B, Singh A, Wang B, Antiochos B, Geetha D. Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis. Kidney Int Rep. 2025 Jun;10(6):2065–8.
Cammarata, Michael, et al. “Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.” Kidney Int Rep, vol. 10, no. 6, June 2025, pp. 2065–68. Pubmed, doi:10.1016/j.ekir.2025.04.026.
Cammarata M, Denvir B, Singh A, Wang B, Antiochos B, Geetha D. Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis. Kidney Int Rep. 2025 Jun;10(6):2065–2068.
Published In
Kidney Int Rep
DOI
EISSN
2468-0249
Publication Date
June 2025
Volume
10
Issue
6
Start / End Page
2065 / 2068
Location
United States
Related Subject Headings
- 42 Health sciences
- 32 Biomedical and clinical sciences